Search

  • HOME
  • Search
Review
1759
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra
Clin Mol Hepatol. 2023;29(Suppl):S286-S301.   Published online December 28, 2022
View: 4865   Download: 236  Web of Science: 9  Crossref: 9
1729
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clin Mol Hepatol. 2023;29(Suppl):S43-S57.   Published online November 22, 2022
View: 3399   Download: 150  Web of Science: 13  Crossref: 13
Editorial
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
Philipp Kasper, Münevver Demir, Hans-Michael Steffen
Clin Mol Hepatol. 2023;29(2):390-393.   Published online March 20, 2023
View: 2244   Download: 53  Web of Science: 2  Crossref: 2
Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake
Seonghwan Hwang, Tianyi Ren, Bin Gao
Clin Mol Hepatol. 2020;26(4):586-594.   Published online September 17, 2020
View: 6845   Download: 203  Web of Science: 17  Crossref: 16
Review
NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
Stephen Caldwell
Clin Mol Hepatol. 2017;23(2):103-108.   Published online May 10, 2017
View: 11831   Download: 469  Web of Science: 30  Crossref: 30
1338
Genetic predisposition in nonalcoholic fatty liver disease
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol. 2017;23(1):1-12.   Published online March 9, 2017
View: 17537   Download: 599  Web of Science: 143  Crossref: 141
Original Article
Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH
Min Yong Yoon, Jun Mo Sung, Chang Seok Song, Won Young Lee, Eun Jung Rhee, Jun Ho Shin, Chang Hak Yoo, Seoung Wan Chae, Ja Yeon Kim, Wook Jin, Yong Kyun Cho
Clin Mol Hepatol. 2012;18(3):279-286.   Published online September 25, 2012
View: 6658   Download: 69  Crossref: 11
2
Nonalcoholic steatohepatitis: Pathogenesis and treatment
Sang Hoon Park
Clin Mol Hepatol. 2008;14(1):12-27.   Published online March 20, 2008
View: 6792   Download: 103  Crossref: 5
5
Nonalcoholic Steatohepatitis
So-Young Jin
Clin Mol Hepatol. 2006;12(3):455-459.   Published online January 1, 2000
View: 2523   Download: 20
3
The Prevalence of Metabolic Syndrome in Patients with Nonalcoholic Fatty Liver Disease
Ki Won Moon, M.D., Joung Muk Leem, M.D., Sang Seok Bae, M.D., Ki Man Lee, M.D., Seok Hyung Kim, M.D.*, Hee Bok Chae, M.D., Seon Mee Park, M.D. and Sei Jin Youn, M.D.
Clin Mol Hepatol. 2004;10(3):197-206.   Published online January 1, 1970
View: 3056   Download: 58
Original Article
Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Michael H. Le, David M. Le, Thomas C. Baez, Hansen Dang, Vy H. Nguyen, KeeSeok Lee, Christopher D. Stave, Takanori Ito, Yuankai Wu, Yee Hui Yeo, Fanpu Ji, Ramsey Cheung, Mindie H. Nguyen
Received November 1, 2023  Accepted January 26, 2024  
View: 863   Download: 126
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 2930
TOTAL : 1738938
Close layer